Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v5-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2019-07-05 | 2019-04-10 |
Drug Identification Number | 02430827 | 02430827 |
Brand name | LINEZOLID INJECTION | LINEZOLID INJECTION |
Common or Proper name | Linezolid Injection | Linezolid Injection |
Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
Ingredients | LINEZOLID | LINEZOLID |
Strength(s) | 2MG | 2MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS | INTRAVENOUS |
Packaging size | 300mL | 300mL |
ATC code | J01XX | J01XX |
ATC description | OTHER ANTIBACTERIALS | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-04-11 | 2019-04-11 |
Actual start date | ||
Estimated end date | 2019-06-28 | 2019-06-28 |
Actual end date | 2019-07-04 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Replenishment inventories of our Linezolid Injection 2 mg/mL freeflex® Bag 300 mL will be available at all distribution centres effective July 4, 2019 | Please note that the stockout date may vary by region; please check your local distribution centre for stock availability. Pfizer is an alternate supplier of Linezolid Injection 2 mg/mL Bag 300 mL and have been informed of our impending supply interruption. |
Health Canada comments |